- In March 2024, Merck Invests More than euro 300 Million in New Life Science Production Site in Korea. This New Bioprocessing Production Center in Daejeon strengthened footprint of Merck in fast-growing Europe region.
- In October 2024, Thermo Fisher introduced new biopreservation media optimized for cell and gene therapy, aiming to improve viability and stability during storage and transport—supporting the growing demand for advanced preservation solutions across Europe’s regenerative medicine sector.
- In September 2024, Merck KGaA unveiled a line of next-generation cryopreservation solutions tailored for biopharma and research applications in Europe, designed to ensure higher post-thaw recovery of cells and tissues for clinical and laboratory use.
- In November 2024, BASF SE partnered with Acies Bio to develop sustainable fermentation-based production methods for personal and home care preservatives, reinforcing its commitment to eco-friendly biopreservation solutions across European industries.
- In March 2024, STEMCELL Technologies introduced specialized media for preserving hematopoietic stem cells in Europe, enhancing cell recovery and post-thaw functionality—addressing critical needs in stem cell research and therapy.
